[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

Year

Day

February 16, 2017
Cancer Care Chronicles

Bath

Abstract Full Text
JAMA Oncol. Published online February 16, 2017. doi:10.1001/jamaoncol.2016.6132
Editorial

Improving the Evidence Base for Delivery of High-Quality Cancer Care

Abstract Full Text
JAMA Oncol. Published online February 16, 2017. doi:10.1001/jamaoncol.2016.6722
Original Investigation

Comparison of Patient Report and Medical Records of ComorbiditiesResults From a Population-Based Cohort of Patients With Prostate Cancer

Abstract Full Text
free access
JAMA Oncol. Published online February 16, 2017. doi:10.1001/jamaoncol.2016.6744

This population-based cohort study examines the agreement between medical records and patient report in assessing comorbidities.

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Abstract Full Text
JAMA Oncol. Published online February 16, 2017. doi:10.1001/jamaoncol.2016.6749

This study evaluates self-reporting of symptomatic adverse events associated with treatment of cancer in patients participating in clinical trials.

Research Letter

Independent Validation of Effect of HSD3B1 Genotype on Response to Androgen-Deprivation Therapy in Prostate Cancer

Abstract Full Text
JAMA Oncol. Published online February 16, 2017. doi:10.1001/jamaoncol.2017.0147

Using data from a prostate cancer registry, this study correlated HSD3B1 genotype with response to androgen-deprivation therapy in patients with prostate cancer.

Correction

Incorrect Data and Reworded Paragraphs

Abstract Full Text
free access
JAMA Oncol. Published online February 16, 2017. doi:10.1001/jamaoncol.2017.0099
February 15, 2017
Viewpoint

Impact of US Immigration Ban on Oncologists and PatientsOncology Knows No Borders

Abstract Full Text
free access
JAMA Oncol. Published online February 15, 2017. doi:10.1001/jamaoncol.2017.0435

This Viewpoint describes the disproportionate domestic impact on rural and inner-city citizens of the United States caused by the recent immigration and travel ban, and seeks to affirm physicians’ commitment to more and not less diversity and inclusion.

February 14, 2017
From The JAMA Network

Do the Data on Scalp Cooling for Patients With Breast Cancer Warrant Broad Adoption?

Abstract Full Text
JAMA Oncol. Published online February 14, 2017. doi:10.1001/jamaoncol.2017.0051

This review looks at scalp cooling, an intervention that can prevent or reduce the severity of chemotherapy-induced alopecia.

February 9, 2017
Viewpoint

Having a Conversation With a Patient With Incurable Cancer—Just Another Protocol?

Abstract Full Text
JAMA Oncol. Published online February 9, 2017. doi:10.1001/jamaoncol.2016.6776

This Viewpoint examines the need for physicians to approach end-of-life conversations with patients with terminal cancer prognoses with flexibility and an understanding of patient desires and needs.

Editorial

JAMA Oncology—The Year in Review, 2016

Abstract Full Text
free access
JAMA Oncol. Published online February 9, 2017. doi:10.1001/jamaoncol.2016.7045
Original Investigation

Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing ResultsAnalysis of Phase 3 SWOG Intergroup Trial S0033

Abstract Full Text
JAMA Oncol. Published online February 9, 2017. doi:10.1001/jamaoncol.2016.6728

This follow-up of a randomized clinical trial evaluates long-term survival in patients with gastrointestinal stromal tumors who were treated with 1 of 2 dose levels of imatinib mesylate and presents new molecular data regarding treatment outcomes.

Effect of Radiotherapy on Painful Bone MetastasesA Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23

Abstract Full Text
JAMA Oncol. Published online February 9, 2017. doi:10.1001/jamaoncol.2016.6770

This secondary analysis of a National Cancer Institute of Canada trial investigates quality of life at days 10 and 42 after radiotherapy with a bone metastases–specific quality-of-life tool.

From The JAMA Network

An Important Step Forward for Biosimilars in Cancer Treatment

Abstract Full Text
JAMA Oncol. Published online February 9, 2017. doi:10.1001/jamaoncol.2016.6789

This commentary discusses the findings of a randomized clinical trial of trastuzumab vs a biosimilar in patients with metastatic breast cancer that was published in JAMA and posits 3 questions for consideration moving forward in the development and clinical use of biosimilars.

JAMA Oncology Clinical Challenge

Headache in the Setting of Immunotherapy Treatment for Metastatic Melanoma

Abstract Full Text
JAMA Oncol. Published online February 9, 2017. doi:10.1001/jamaoncol.2016.6611

A woman with metastatic melanoma receiving ipilimumab and nivolumab developed headaches during the course of her treatment and reported low energy levels and difficulty reading. What is your diagnosis?

Editor's Note

Single-Fraction Radiotherapy and Early Subjective Improvement in Pain

Abstract Full Text
free access
JAMA Oncol. Published online February 9, 2017. doi:10.1001/jamaoncol.2016.6723
Correction

Clarification of Conflict of Interest Disclosure

Abstract Full Text
free access
JAMA Oncol. Published online February 9, 2017. doi:10.1001/jamaoncol.2017.0067
Peer Reviewers List

JAMA Oncology Peer Reviewers in 2016

Abstract Full Text
free access
JAMA Oncol. Published online February 9, 2017. doi:10.1001/jamaoncol.2017.0110
February 3, 2017
Cancer Care Chronicles

From Muslim Registries to Radical Health Care Reform—Caring for Patients in an Era of Political Anxiety

Abstract Full Text
JAMA Oncol. Published online February 3, 2017. doi:10.1001/jamaoncol.2017.0151
February 2, 2017
Viewpoint

Human-Machine Collaboration in Cancer and BeyondThe Centaur Care Model

Abstract Full Text
JAMA Oncol. Published online February 2, 2017. doi:10.1001/jamaoncol.2016.6413

This Viepoint examines the implementation and possible benefits of human-machine collaboration in treating patients with cancer.

Original Investigation

Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer

Abstract Full Text
JAMA Oncol. Published online February 2, 2017. doi:10.1001/jamaoncol.2016.6326

This population-based, case-control, cohort study uses data from the Breast Cancer Surveillance Consortium to assess risk factors associated with breast cancer in premenopausal and postmenopausal women.

Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States

Abstract Full Text
JAMA Oncol. Published online February 2, 2017. doi:10.1001/jamaoncol.2016.6380

This cohort study investigates temporal patterns and factors associated with the receipt of adjuvant endocrine therapy in women with breast cancer in the National Cancer Database.

Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

Abstract Full Text
JAMA Oncol. Published online February 2, 2017. doi:10.1001/jamaoncol.2016.6435

This case-control study assesses the association of cytotoxic, anti-inflammatory, and immunomodulating agents with the risk for developing myeloid neoplasms among patients with autoimmune disease.

Research Letter

Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015

Abstract Full Text
JAMA Oncol. Published online February 2, 2017. doi:10.1001/jamaoncol.2016.6416

This study examines whether low-dose computed tomography screening for lung cancer increased following the United States Preventive Services Task Force recommendations.

Correction

Error in Methods Section

Abstract Full Text
free access
JAMA Oncol. Published online February 2, 2017. doi:10.1001/jamaoncol.2017.0054
×